Search results for "Alprazolam"

showing 10 items of 18 documents

Center differences and cross-national invariance in help-seeking for panic disorder. A report from the cross-national collaborative panic study.

1992

Help-seeking behaviour for treatment of panic disorder was investigated in the sample of the Cross-National Collaborative Panic Study Second Phase. A total of 1168 patients were entered into this trial in 14 countries. Although there were significant center differences in prior treatment and utilization of health services there were also similarities. Treatment had been provided mainly by general practitioners. Drug treatment consisted mostly of prescription of classical tranquilizers and had a longer duration than treatment by psychotherapy. Patients with agoraphobic avoidance, past major depression and longer duration of illness used medical and psychiatric treatment facilities more inten…

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyImipramineHealth (social science)Social PsychologyEpidemiologyPharmacotherapyEpidemiologymedicineHumansMedical prescriptionPsychiatryDepression (differential diagnoses)Alprazolambusiness.industryPanic disorderIncidencePanicPatient Acceptance of Health Caremedicine.diseaseHelp-seekingPsychiatry and Mental healthCross-Sectional StudiesPanic DisorderFemalemedicine.symptombusinessAnxiety disorderClinical psychologySocial psychiatry and psychiatric epidemiology
researchProduct

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

1994

Summary Side effects play a significant role in the selection of drugs to be used in panic disorder/agoraphobia whose polyphobic symptomatology often includes a suspiciousness about taking drugs and a fear of undesired side effects which may lead to the refusal of treatment. The safety, side effects and patients' acceptance of alprazolam and imipramine versus placebo were evaluated in 1168 subjects with panic disorder/agoraphobia who had been enrolled in the second phase of the Upjohn World Wide Panic Study. Side effects that worsened over baseline to a greater extent with alprazolam than with imipramine and placebo were sedation, fatigue/weakness, memory problems, ataxia and slurred speech…

AdultImipramineAdolescentSide effectPoison controlPlaceboImipramineDouble-Blind MethodmedicineHumansPharmacology (medical)Biological PsychiatryAgedPsychiatric Status Rating ScalesPharmacologyAlprazolambusiness.industryPanic disorderPanicMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologyAlprazolamAnesthesiaPanic DisorderPatient ComplianceNeurology (clinical)medicine.symptombusinessAgoraphobiamedicine.drugEuropean Neuropsychopharmacology
researchProduct

Drug treatment of panic disorder: early response to treatment as a predictor of final outcome

1990

One of the core problems in clinical research is the detection of early changes in target symptoms that predict future therapeutic outcome. To analyze potential predictors of outcome, data of a multicenter study on patients with panic disorder were used. A total of 1010 patients were randomly allocated either to alprazolam, imipramine or placebo treatment. Early improvement in the number of spontaneous panic attacks within the first week of treatment predicted outcome exclusively in the alprazolam group. In contrast, placebo responders and nonresponders were differentiated by early changes in anticipatory anxiety intensity. For tricyclic antidepressants such as imipramine an evaluation peri…

AdultMaleImipraminemedicine.medical_specialtyPlaceboImipramineDouble-Blind MethodInternal medicinemedicineHumansPsychiatryAgoraphobiaPsychiatric Status Rating Scaleschemistry.chemical_classificationAlprazolamPanic disorderPanicmedicine.diseaseAnxiety DisordersPanicPsychiatry and Mental healthClinical researchchemistryAlprazolamAnxietyFemalemedicine.symptomArousalPsychologyTricyclicmedicine.drugActa Psychiatrica Scandinavica
researchProduct

Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment

1991

In order to establish the clinical validity of currently used ways of subtyping panic disorder the predictive power of associated current avoidance behaviour and (secondary) major depression for the response to active treatment (alprazolam, imipramine) was tested. The analysis was based on the data from the Cross-National-Collaborative-Panic-Study. Limited support for validity evidenced by predicting drug response was found for grading panic disorder by the severity of avoidance behaviour; patients with panic attacks and agoraphobia are more responsive to imipramine (compared with alprazolam) when using the reduction of the total number of panic attacks (or of spontaneous panic attacks) as …

AdultMaleImipraminemedicine.medical_specialtySocial Environmentbehavioral disciplines and activitiesImipraminelaw.inventionDouble-Blind MethodRandomized controlled triallawmental disordersmedicineHumansPharmacology (medical)PsychiatryAgoraphobiaBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive DisorderAlprazolamPanic disorderPanicGeneral MedicinePrognosismedicine.diseaseAnxiety DisordersPanichumanitiesSubtypingPsychiatry and Mental healthAlprazolamFemalemedicine.symptomPsychologymedicine.drugAgoraphobiaClinical psychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Separate and Combined Effects of a Benzodiazepine (Alprazolam) and Noise on Auditory Brainstem Responses in Man

1999

Auditory brainstem responses (ABRs) were recorded in 60 male or female, anxious or anxiety-free university students, before and after separated or simultaneous intake of alprazolam and exposure to noise. A significant increase of the latencies of the ABRs was found when subjects took alprazolam. This effect is consistent with the presence of gamma-aminobutyric acid (GABA), one of the neurotransmitters at terminals of cochlear efferent fibres A significant increase of the latencies was observed after noise alone. In subjects taking alprazolam when they are exposed to noise, the effect of noise on the ABR latencies is reduced, but not abolished. The effects of alprazolam on the ABR are consis…

AdultMaleLinguistics and Languagemedicine.medical_specialtyAdolescentmedicine.drug_classAnxietyAudiologyLanguage and LinguisticsSpeech and HearingCochlear efferentReference ValuesPonsEvoked Potentials Auditory Brain StemReaction Timeotorhinolaryngologic diseasesHumansMedicineAuditory Fatiguegamma-Aminobutyric AcidMedullaMedulla OblongataBenzodiazepineAlprazolambusiness.industryPonsNoiseAnti-Anxiety AgentsAlprazolamAnxietyFemaleBrainstemmedicine.symptomNoisebusinessmedicine.drugInternational Journal of Audiology
researchProduct

Avoidance behaviour: A predictor of the efficacy of pharmacotherapy in panic disorder?

1991

The impact of the avoidance behaviour on the psychopharmacological treatment of panic disorder was explored in the Cross National Collaborative Panic Study (n = 1134 patients); in this double blind randomized trial alprazolam, imipramine and placebo were compared during an 8-week treatment period. Patients with extensive avoidance behaviour (agoraphobia) had the most profit from the active drugs. Counter expectancy these specific drug effects were most pronounced in avoidance behaviour. Active drugs (in particular imipramine) were especially more effective than placebo if the patients presented with associated avoidance behaviour. The results suggest that agoraphobia defines more a particul…

AdultMalePersonality TestsImipraminemedicine.medical_specialtyPlacebobehavioral disciplines and activitiesImipraminelaw.inventionDouble-Blind MethodRandomized controlled triallawmental disordersmedicineHumansPharmacology (medical)Social BehaviorPsychiatryAgoraphobiaBiological PsychiatryAlprazolamPanic disorderPanicFearGeneral Medicinemedicine.diseasePanichumanitiesPsychiatry and Mental healthAlprazolamPanic DisorderFemalemedicine.symptomArousalPsychologyAnxiety disordermedicine.drugAgoraphobiaClinical psychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborati…

1991

The relevance of the chronology between panic disorder and avoidance behavior and of an early, medium or late onset of panic disorder was tested. Groups from the sample of the cross-national collaborative panic study (CNCPS) were compared for differences in basic characteristics and for the ability to predict treatment response. Patients who developed avoidance behavior before the full syndrome of panic disorder had less often a full agoraphobia but were not different in their response to treatment. Patients with an early onset of panic disorder suffered more often from agoraphobia. The treatment response was similar in the groups with early, medium or late onset of panic disorder. Neither …

AdultMalePersonality Testsmedicine.medical_specialtyImipramineLate onsetbehavioral disciplines and activitiesImipramineDrug Administration Schedulelaw.inventionRandomized controlled triallawmental disordersmedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAlprazolamGeneral NeurosciencePanic disorderAge FactorsPanicGeneral MedicineMiddle Agedmedicine.diseasePrognosisAnxiety DisordersPanichumanitiesPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAlprazolamFemalemedicine.symptomAge of onsetPsychologyArousalmedicine.drugClinical psychologyAgoraphobiaEuropean archives of psychiatry and clinical neuroscience
researchProduct

Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.

1990

The Marks-Sheehan anxiety scales are the only scales where self-ratings and observer ratings are perfectly matched by the number, the content and the scaling of the items. Therefore these scales are an excellent tool to investigate the compatibility and to study different structures in self- and observer ratings. This was done by using the data material on the Marks-Sheehan scales of the Cross National Collaborative Panic Study. In this study 1168 outpatients who met the DSM-III criteria for panic disorder were randomly allocated either to alprazolam, imipramine or placebo treatment. Our results show that the Marks-Sheehan scales are highly comparable to other established rating scales. Bot…

AdultPersonality TestsImipraminePersonality Assessmentbehavioral disciplines and activitiesDouble-Blind MethodRating scalemedicineHumansPharmacology (medical)Biological PsychiatryAlprazolamGeneral NeurosciencePanic disorderSelfBehaviorally anchored rating scalesPanicGeneral MedicineMiddle Agedmedicine.diseaseAnxiety DisordersPanicObserver ratingPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAlprazolamAnxietymedicine.symptomPsychologySocial psychologymedicine.drugClinical psychologyEuropean archives of psychiatry and clinical neuroscience
researchProduct

Self- and observer assessment in anxiolytic drug trials: A comparison of their validity

1990

Self-rating scales are considered to be less useful for comparing different treatments in anxiety patients than observer-rating scales. However, the empirical evidence for this assumption is not adequate. A self-rating inventory of 35 items related to anxiety was perfectly parallel with an observer-rating inventory. Both instruments were used in the Cross National Collaborative Panic Study to compare the efficacy of imipramine, alprazolam and placebo in an 8-week drug trial in a sample of 1168 outpatients. The variance of the self-rating assessments was about two times higher. Both scales were equally sensitive to change; however, the measurement of change by means of the self-rating scale …

AdultPersonality TestsImipraminemedicine.medical_specialtyPsychometricsPsychometricsmedicine.drug_classPersonality AssessmentAnxiolyticDouble-Blind MethodRating scalemedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAlprazolamGeneral NeurosciencePanic disorderReproducibility of ResultsPanicGeneral MedicineMiddle Agedmedicine.diseaseAnxiety DisordersPanicPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAlprazolamAnxietymedicine.symptomPersonality Assessment InventoryPsychologyClinical psychologymedicine.drugEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Locomotor and antidepressant-like effects of 5-HT(1A) agonist LY 228729 in prenatally benzodiazepine-exposed rats.

1998

Locomotor activity and antidepressant-like effect in the forced swim test (FST) of 5-HT(1A) agonist LY 228729 were investigated in adult rats prenatally exposed at doses of diazepam (DZ) and alprazolam (ALP) which induce persistent downregulation of GABA/ benzodiazepine (BZ) receptors. Prenatal exposure to ALP and DZ did not modify the efficacy of subchronic LY 228729 to decrease immobility time in the FST. Prenatal DZ and ALP potentiated the facilitatory effect of subchronic LY 228729 on locomotor activity; prenatal DZ was more effective than prenatal ALP. Moreover, prenatal DZ increased stereotypic movements induced by LY 228729. These data suggest that the persistent downregulation of GA…

AgonistMalemedicine.drug_classInjections SubcutaneousPharmacologyMotor ActivityRats Sprague-DawleyDownregulation and upregulationPregnancymedicineAnimalsPharmacology (medical)ErgolinesReceptorBiological Psychiatry5-HT receptorSwimmingPharmacologyBenzodiazepineDepressive DisorderDiazepamAlprazolamChemistrymusculoskeletal neural and ocular physiologyAntidepressive AgentsRatsSerotonin Receptor AgonistsPsychiatry and Mental healthNeurologyAlprazolamAnti-Anxiety AgentsPrenatal Exposure Delayed EffectsFemaleNeurology (clinical)Stereotyped Behaviorhuman activitiesDiazepammedicine.drugBehavioural despair testEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct